Navigation Links
Smell may outlast other senses

About 1000 Australian males and females of all ages were tested for their ability to detect or identify a range of different odours at different concentrations, and then given an overall score for their sense of smell, or olfactory function.

The results showed that olfactory function deteriorates relatively slowly with age in those who do not smoke, take medications or have a history of nasal problems such as sinusitis.

However the ability to smell drops off much quicker in older people who were taking medications ?also an indicator of underlying health problems.

Researcher Dr Amy Johnston, from Griffith University’s School of Nursing and Midwifery and the Eskitis Institute of Cell and Molecular Biology, said the study suggested that aging alone had a small detrimental effect on smell.

“However our sense of smell is vulnerable to both the direct effects of some medications and changes associated with a number of neurodegenerative illnesses. Exposure to these factors typically increases with age.?

Anticholesterol and blood pressure lowering medications were amongst the common drugs known to interfere with smell. Conditions such as Parkinson’s disease and Alzheimer’s disease were also associated with impairment in the sense of smell, she said.

Dr Johnston said the ability to smell was an important factor in the enjoyment of food flavours.

“People who lose their sense of smell, particularly the elderly, are at risk of poor appetite and subsequent poor nutrition. Smell is also an important warning sense ?telling people when food is not fit for consumption.?

Healthy women were shown to have a more sensitive sense of smell than healthy men but the gender effect was not apparent in smokers, people on medications or with a history of nasal problems.


'"/>

Source:Research Australia


Page: 1

Related biology news :

1. Smell of success for nanobiosensors
2. Get a whiff of this: Smell test could sniff out serious health problems
3. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
4. Another Look Finds Promising Proteomics Test is Not Biologically Plausible
5. Elephants imitate truck noises, other animals
6. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
7. NJIT Presidential Award winner takes stem cell research another step
8. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
9. NASA links nanobacteria to kidney stones and other diseases
10. Anti cancer virotherapy well tolerated in first human administration, research finds
11. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Research and Markets has announced the addition of the "Global ... 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market is ... next decade to reach approximately $14.21 billion by 2025. ... all the given segments on global as well as regional levels ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017  Northwest Biotherapeutics (OTCQB: ... personalized immune therapies for solid tumor cancers, today ... million financing it announced last Friday, March 17, ... several institutional investors securities totaling 28,843,692 shares, comprised ... and 10,000,000 shares of Class C Warrants pre-funded ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... New Orleans, La. (PRWEB) , ... March 23, ... ... of real-time, industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” ... for APMT customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s ...
(Date:3/22/2017)... Good Start Genetics, a leading family genomics ... million covered lives mark through its most recent payor ... . With newly signed contracts nationally and others ... payor acceptance based on the quality of its science, ... its industry-leading customer care and support and its published ...
Breaking Biology Technology: